Process intensification has become a hot topic in biopharma in recent years, with concepts like continuous manufacturing and “scaling-out” increasingly cited as investment drivers by drug firms and ...
Although all this growth is encouraging, it is also straining global manufacturing capacities. Biopharma manufacturers are under pressure to find innovative platform technologies to bring products to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results